MERS-CoV Emerges in Symptomatic Camels in Kazakhstan’s Mangystau Region
A 2025 respiratory outbreak in camels from southwestern Kazakhstan ended with a molecular confirmation that matters far beyond the affected herds: MERS-CoV was actively circulating in Central Asia. Investigators detected viral RNA in all 38 symptomatic camels they sampled, linking the outbreak to a zoonotic betacoronavirus long associated with dromedary reservoirs and severe human disease.
The finding extends the known geographic range of MERS-CoV activity into a region where prior work had raised suspicion without securing direct molecular proof. Earlier serologic studies in Kazakhstan suggested exposure in camelids, but RNA had not been recovered from asymptomatic animals sampled in 2020 or from symptomatic camels sampled in 2023. This time, the signal was unmistakable: acutely ill animals, clear respiratory signs, and consistent positivity by qRT-PCR across every sampled case.
Respiratory Disease Spread Through Mixed Camel Herds in Winter
The outbreak began in late November 2025 in the Mangystau region, where temperatures were below freezing and camel production relies on extensive pastoral and seminomadic systems. Herds in the area often move seasonally and congregate at shared grazing and watering points, creating the sort of contact network that can sustain pathogen exchange between animals. The outbreak involved mainly dromedaries, though Bactrian camels were also affected in mixed herds.
Clinical disease was straightforward but alarming: lacrimation, nasal discharge, and intermittent cough in both juvenile and adult camels. Breeders and veterinary practitioners reported similar respiratory illness across multiple areas of Mangystau, and comparable illness was also described in neighboring Turkistan region. In practical terms, this was not a single farm problem. It was a regional livestock event moving through a connected animal population.
During December 1–18, 2025, investigators collected nasopharyngeal swabs from 38 symptomatic camels from multiple affected herds and households in different settlements. Those samples represented about 1.2% of the 3,190 camels registered in the affected rural district. Four months later, follow-up swabs from 14 camels in previously affected herds were negative by qRT-PCR, suggesting that viral shedding had resolved by then.
qRT-PCR Positivity Confirmed Active Viral Shedding
Laboratory testing established the core virologic point quickly. All 38 swab samples were positive for MERS-CoV RNA by qRT-PCR assays targeting the upstream envelope and ORF1a regions. Ct values were compatible with active infection, with upE ranging from 23.14 to 33.09 and ORF1a ranging from 14.33 to 31.09. Lower Ct values in a subset of specimens indicate substantial viral RNA burden in at least some animals, consistent with ongoing shedding during the outbreak window.
Other likely respiratory pathogens were excluded in parallel. Molecular assays for influenza A and D viruses, bovine paramyxovirus, and herpesviruses were negative in the sampled camels, narrowing the outbreak explanation to MERS-CoV rather than a broader mixed-pathogen syndrome. That pattern strengthens the epidemiologic argument that the coronavirus was not an incidental finding in a background of unrelated respiratory disease.
Genome Data Linked Kazakhstan Viruses to Contemporary Arabian Lineages
Sequencing moved the story from detection to evolutionary context. Investigators amplified partial RNA-dependent RNA polymerase fragments from selected positive samples, then generated one complete genome and four complete spike gene sequences from outbreak-associated viruses. Phylogenetic analysis placed the Kazakhstan genome in clade B5, clustering with camel-derived viruses from Saudi Arabia and Egypt collected in 2023–2024.
The spike sequences fell within the recently described B5-2023.4 sublineage and formed a well-supported cluster with contemporary camel viruses from Saudi Arabia. Several substitutions seen in the Kazakhstan viruses, including P97L, G198D, and L495P, matched changes previously reported among related B5-2023.4 viruses. Two of the substitutions discussed in the analysis, L450F and L495P, sit in the receptor-binding domain, the region that governs attachment to host receptors and therefore carries direct relevance for host interaction biology.
A brief result stands out: the Kazakhstan virus was not an isolated local oddity but part of a wider, moving viral lineage.
Recombination Signals Raise Evolutionary Questions
Recombination analysis identified two putative events involving the Kazakhstan genome, supported by multiple independent detection methods. The inferred recombinant regions overlapped with regions previously described among contemporary B5 viruses from Saudi Arabia, although one parental lineage could not be assigned with certainty. Such findings fit with recurrent within-lineage recombination already described for MERS-CoV, where genome shuffling can accompany continued circulation in camel reservoirs.
The biological implications remain unsettled, because sequence data alone cannot determine whether these events altered phenotype, fitness, or transmission efficiency. Even so, recurrent recombination in a zoonotic coronavirus reservoir is not a trivial observation. It reflects a viral population still actively evolving inside the animal host network that sustains human spillover risk.
Zoonotic Risk Extends Beyond the Arabian Peninsula
The Kazakhstani data fill an important geographic gap. Prior regional studies had not shown active MERS-CoV RNA circulation, and nationwide screening during 2020–2021 did not find antibodies in sampled camels. Active infection detected during the 2025 outbreak now demonstrates that the virus can circulate in Central Asian camel populations rather than being confined to the Arabian Peninsula and parts of Africa.
Age distribution also matters. The virus was detected in both juvenile and adult camels. In endemic settings, juveniles are often sampled more frequently because they shed virus more readily, but adults remain susceptible to infection and reinfection. Finding positives across age groups in this outbreak supports ongoing herd transmission rather than a narrow, age-restricted event.
The regional livestock context adds another layer of concern. Mangystau sits within cross-border movement networks that connect Central Asia with neighboring regions, and increasing connectivity with the Arabian Peninsula may facilitate transboundary dissemination of zoonotic pathogens. The combination of mixed herds, shared watering points, seasonal movement, and cross-border trade creates a plausible route for viral spread even when human cases are not yet detected.
No human MERS cases were identified in connection with the 2025 camel outbreak in Kazakhstan. Even so, the absence of recognized spillover should not be mistaken for absence of risk. When viral shedding occurs in a high-density camel region bordering multiple countries, veterinary surveillance becomes the first line of defense for human health.
The most concrete unresolved issue is whether climate, animal movement, or herd structure shaped the winter outbreak in Kazakhstan, because the event occurred in freezing conditions rather than the warmer seasonal peaks often reported in endemic regions. The available data do not answer that question, and they do not establish the direction of virus movement. They do, however, show that active MERS-CoV infection is now documented in Kazakhstan camels, making expanded surveillance and genomic monitoring necessary for the region’s animal and public health systems.